CHPA Response to Study of Tampon Products

(WASHINGTON, D.C.) - The Consumer Healthcare Products Association (CHPA) released the following statement in response to a recent study published in Environment International reporting that metals were present in certain tampon products. The study did not assess the risk of metal exposure to tampon users.

Consumer trust is a responsibility CHPA member companies take very seriously, and their commitment to ensuring consumer safety remains the top priority. Our members strictly adhere to Current Good Manufacturing Practices (CGMPs) outlined in the Federal Food, Drug and Cosmetic Act (FDCA) and abide by all regulations, guidelines, and procedures set forth by the U.S. Food and Drug Administration (FDA).

Before tampons can be legally marketed in the United States, they must undergo FDA's review process. Manufacturers are required to submit data, including results evaluating the safety of the materials used to make the tampons and applicators, which demonstrates that they can be safely used in or on the human body.

This study did not assess if any metals are released from tampons when used in the body and did not document any health risks to tampon users. To reaffirm safety, FDA has commissioned an independent literature review and an internal laboratory study and will share results publicly once they are peer-reviewed. CHPA remains supportive of continued research to help ensure the safe use of these products.